ATE369128T2 - Tamsulosin tabletten ohne nahrungsmitteleffekt - Google Patents

Tamsulosin tabletten ohne nahrungsmitteleffekt Download PDF

Info

Publication number
ATE369128T2
ATE369128T2 AT02780143T AT02780143T ATE369128T2 AT E369128 T2 ATE369128 T2 AT E369128T2 AT 02780143 T AT02780143 T AT 02780143T AT 02780143 T AT02780143 T AT 02780143T AT E369128 T2 ATE369128 T2 AT E369128T2
Authority
AT
Austria
Prior art keywords
food effect
tamsulosin tablets
tamsulosin
tablets
food
Prior art date
Application number
AT02780143T
Other languages
English (en)
Inventor
Jacobus Lemmens
Johannes Platteeuw
Dalen Frans Van
Arturo Ortega
Juan Escoi
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23292437&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE369128(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Synthon Bv filed Critical Synthon Bv
Application granted granted Critical
Publication of ATE369128T2 publication Critical patent/ATE369128T2/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02780143T 2001-11-07 2002-11-06 Tamsulosin tabletten ohne nahrungsmitteleffekt ATE369128T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33105501P 2001-11-07 2001-11-07

Publications (1)

Publication Number Publication Date
ATE369128T2 true ATE369128T2 (de) 2007-08-15

Family

ID=23292437

Family Applications (3)

Application Number Title Priority Date Filing Date
AT02775597T ATE321544T1 (de) 2001-11-07 2002-11-01 Tamsulosin tabletten
AT02780143T ATE369128T2 (de) 2001-11-07 2002-11-06 Tamsulosin tabletten ohne nahrungsmitteleffekt
AT0084805U AT9978U1 (de) 2001-11-07 2005-12-12 Tamsulosin-hältige matrixtablette

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT02775597T ATE321544T1 (de) 2001-11-07 2002-11-01 Tamsulosin tabletten

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT0084805U AT9978U1 (de) 2001-11-07 2005-12-12 Tamsulosin-hältige matrixtablette

Country Status (21)

Country Link
US (2) US20030147950A1 (de)
EP (3) EP1443917B1 (de)
JP (3) JP2005512997A (de)
CN (3) CN1298317C (de)
AT (3) ATE321544T1 (de)
AU (1) AU2002301845B2 (de)
CA (2) CA2465110A1 (de)
CZ (3) CZ16814U1 (de)
DE (4) DE60210315T2 (de)
DK (3) DK1443917T3 (de)
ES (2) ES2256544T3 (de)
HU (2) HUP0401978A3 (de)
IL (4) IL161491A0 (de)
NL (2) NL1021822C2 (de)
NO (2) NO340960B1 (de)
NZ (2) NZ532589A (de)
PT (2) PT1443917E (de)
RU (2) RU2311903C2 (de)
SI (2) SI1443917T1 (de)
WO (2) WO2003039530A1 (de)
ZA (2) ZA200403281B (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1443917E (pt) † 2001-11-07 2006-06-30 Synthon Bv Comprimidos de tamsulosina
US7018658B2 (en) * 2002-11-14 2006-03-28 Synthon Bv Pharmaceutical pellets comprising tamsulosin
IN192381B (de) * 2002-12-20 2004-04-10 Ranbaxy Lab
US20040253309A1 (en) * 2003-01-27 2004-12-16 Yamanouchi Pharmaceutical Co., Ltd. Enteric sustained-release fine particles of tamsulosin and its salt and manufacturing method thereof
EP1638537A1 (de) * 2003-07-01 2006-03-29 KRKA, tovarna zdravil, d.d., Novo mesto Tamsulosin-kern mit einem überzug aus polyvinylpyrrolidon und polyvinylacetat
EP1673073A4 (de) * 2003-09-29 2012-03-21 Cj Cheiljedang Corp Formulierungen mit verzögerter freisetzung
KR100762846B1 (ko) * 2003-09-29 2007-10-04 씨제이 주식회사 서방성 제제
JP2005104914A (ja) * 2003-09-30 2005-04-21 Kyowa Yakuhin Kogyo Kk 塩基性薬剤含有製剤
JP2005162736A (ja) * 2003-11-10 2005-06-23 Astellas Pharma Inc 徐放性医薬組成物
JP2005162737A (ja) * 2003-11-10 2005-06-23 Astellas Pharma Inc 徐放性医薬組成物
US8128958B2 (en) 2003-11-10 2012-03-06 Astellas Pharma Inc. Sustained release pharmaceutical composition
US8197846B2 (en) * 2003-11-10 2012-06-12 Astellas Pharma Inc. Sustained release pharmaceutical composition
AU2003286415A1 (en) * 2003-12-03 2005-06-24 Natco Pharma Limited An improved pharmaceutical formulation containing tamsulosin salt and a process for its preparation
SI21702A (en) * 2004-01-29 2005-08-31 Lek Farmacevtska Druzba Dd Preparation of amorphous form of tamsulosin
JP4603803B2 (ja) * 2004-01-30 2010-12-22 大洋薬品工業株式会社 放出制御医薬組成物およびこれを用いる製剤
PL204079B1 (pl) * 2004-08-12 2009-12-31 Inst Farmaceutyczny Stały doustny preparat chlorowodorku tamsulozyny o przedłużonym uwalnianiu i sposób jego wytwarzania
WO2006055659A2 (en) * 2004-11-15 2006-05-26 Smithkline Beecham Corporation Fixed dose combination op dutasteride and tamsulosin
RU2390354C2 (ru) * 2004-12-27 2010-05-27 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Препарат матричного типа с замедленным высвобождением, содержащий основное лекарственное средство или его соль, и способ его получения
US8481565B2 (en) 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20060160852A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Composition containing anti-dementia drug
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
KR100678421B1 (ko) * 2005-02-11 2007-02-02 주식회사 씨티씨바이오 염산 탐스로신 함유 방출조절 제제
JP5597343B2 (ja) * 2005-04-28 2014-10-01 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬を含有する組成物
CN1895241B (zh) * 2005-07-12 2010-05-12 可隆制药株式会社 盐酸坦洛新的口服长效性小药丸组成物及其制造方法
WO2007017253A1 (de) * 2005-08-10 2007-02-15 Add Advanced Drug Delivery Technologies Ltd. Orales präparat mit kontrollierter freisetzung eines benzolsulfonamids
KR20070021806A (ko) * 2005-08-19 2007-02-23 (주)아모레퍼시픽 α1-수용체 차단제의 서방형 펠렛제제 및 이의 제조 방법
KR20070044911A (ko) * 2005-10-26 2007-05-02 주식회사 씨티씨바이오 염산 탐스로신 함유 방출조절 제제
WO2007131804A1 (en) * 2006-05-17 2007-11-22 Synthon B.V. Tablet composition with a prolonged release of tamsulosin
US20090004284A1 (en) * 2007-06-26 2009-01-01 Watson Pharmaceuticals, Inc. Controlled release tamsulosin hydrochloride formulation
EP2042169A1 (de) * 2007-09-26 2009-04-01 LEK Pharmaceuticals D.D. Tabletten zur gesteuerten Freigabe von Tamsulosinhydrochlorid und ein Verfahren für ihre Herstellung
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
US8465770B2 (en) * 2008-12-24 2013-06-18 Synthon Bv Low dose controlled release tablet
WO2011122524A1 (ja) 2010-03-29 2011-10-06 アステラス製薬株式会社 放出制御医薬組成物
US8920840B2 (en) 2010-04-30 2014-12-30 Takeda Pharmaceutical Company Limited Enteric tablet
AU2012259803B2 (en) * 2011-05-25 2016-03-17 Taiho Pharmaceutical Co., Ltd. Dry-coated tablet containing tegafur, gimeracil and oteracil potassium
CN102579392A (zh) * 2012-03-30 2012-07-18 重庆科瑞制药(集团)有限公司 一种含有盐酸坦索罗辛的缓释制剂及其制备方法
US10543174B2 (en) 2016-04-25 2020-01-28 Synthon B.V. Modified release tablet composition comprising mirabegron
SG11202002105WA (en) 2017-09-11 2020-04-29 Atossa Therapeutics Inc Methods for making and using endoxifen
US10478399B2 (en) 2017-10-12 2019-11-19 Synthon B.V. Modified release tablet composition comprising mirabegron
EP3694492A1 (de) 2017-10-12 2020-08-19 Synthon B.V. Tablettenzusammensetzung mit mirabegron mit modifizierter freisetzung
EP3292864A1 (de) 2017-10-12 2018-03-14 Synthon B.V. Tablettenzusammensetzung aus mirabegron mit modifizierter freisetzung
EP4035660A1 (de) 2017-10-17 2022-08-03 Synthon B.V. Tabletten mit tamsulosin und solifenacin
JP7662204B2 (ja) * 2019-07-03 2025-04-15 アトッサ・セラピューティクス・インコーポレイテッド エンドキシフェンの徐放性組成物
US12097189B1 (en) 2024-02-09 2024-09-24 Astellas Pharma Inc. Pharmaceutical composition for modified release

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56110665A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
US5391825A (en) * 1980-02-08 1995-02-21 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl substituted phenethylamine intermediates
SU1440327A3 (ru) * 1980-07-03 1988-11-23 Тейт Энд Лайл Паблик Лимитед Компани (Фирма) Способ получени таблетированной формы препарата
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
EP0205336B1 (de) * 1985-06-11 1991-09-11 Teijin Limited Oral-Arzneizubereitung mit Retardwirkung
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
IE60311B1 (en) * 1987-09-24 1994-06-29 American Home Prod Sustained release etodolac
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
NZ257993A (en) * 1992-11-04 1997-05-26 Sepracor Inc Use of (+)-doxazosin and medicament containing the compound
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
WO1995002419A1 (en) * 1993-07-14 1995-01-26 Yamanouchi Pharmaceutical Co., Ltd. Remedy for urination disorder accompanying prostatic hypertrophy
US5576014A (en) * 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
US5945125A (en) * 1995-02-28 1999-08-31 Temple University Controlled release tablet
JPH09323926A (ja) * 1996-03-15 1997-12-16 Nikken Chem Co Ltd バルプロ酸ナトリウムの徐放性錠剤
CA2275604A1 (en) * 1997-01-03 1998-07-09 Kenneth Iain Cumming Sustained release cisapride mini-tablet formulation
US5843472A (en) * 1997-02-28 1998-12-01 Cygnus, Inc. Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use
JP4221068B2 (ja) * 1997-12-17 2009-02-12 興和創薬株式会社 テオフィリン徐放性錠剤及びその製造方法
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
TW536402B (en) * 1998-06-26 2003-06-11 Yamanouchi Pharma Co Ltd Pharmaceutical composition for the therapy of voiding dysfunction
JP2000080032A (ja) * 1998-06-26 2000-03-21 Yamanouchi Pharmaceut Co Ltd 排出障害治療剤
JP2000128774A (ja) * 1998-10-26 2000-05-09 Tanabe Seiyaku Co Ltd 薬物を含有する球形微粒子の製法
US6419960B1 (en) * 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
PL198797B1 (pl) * 1999-03-31 2008-07-31 Janssen Pharmaceutica Nv Zastosowanie wstępnie żelowanej skrobi
EP1178780B1 (de) * 1999-05-20 2007-07-18 ELAN CORPORATION, Plc Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme
EP1064938A1 (de) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmazeutische Dosierungsformen zur kontrollierte Wirkstoffabgabe mit mindenstens ein pulsierendem Zeitverlauf
JP3154710B1 (ja) * 1999-08-09 2001-04-09 山之内製薬株式会社 下部尿路症治療剤
EP1203582A4 (de) * 1999-08-09 2005-08-03 Yamanouchi Pharma Co Ltd Edizinische zusammenstellung zur behandlung von erkrankungen des unteren harnwegs
GB9924020D0 (en) * 1999-10-11 1999-12-15 Pfizer Ltd Pharmaceutically active compounds
IL141235A (en) * 2000-02-09 2012-04-30 Novartis Int Pharm Ltd Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia
GB0008332D0 (en) * 2000-04-04 2000-05-24 Pfizer Ltd Treament
US6368628B1 (en) * 2000-05-26 2002-04-09 Pharma Pass Llc Sustained release pharmaceutical composition free of food effect
US6287599B1 (en) * 2000-12-20 2001-09-11 Shire Laboratories, Inc. Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
DE10109763A1 (de) * 2001-02-28 2002-09-05 Gruenenthal Gmbh Pharmazeutische Salze
MXPA03000985A (es) * 2001-07-27 2004-04-02 Yamanouchi Pharma Co Ltd Composicion que comprende particulas finas de liberacion sostenida para tabletas de desintegracion rapida en la cavidad bucal y metodo de fabricacion de la misma.
PT1443917E (pt) * 2001-11-07 2006-06-30 Synthon Bv Comprimidos de tamsulosina

Also Published As

Publication number Publication date
CA2464689C (en) 2011-02-01
ZA200403430B (en) 2006-02-22
US20030147955A1 (en) 2003-08-07
HUP0402004A2 (hu) 2005-01-28
DK1441713T3 (da) 2007-12-17
NZ532589A (en) 2005-02-25
US20030147950A1 (en) 2003-08-07
EP1441713B2 (de) 2018-11-14
NO20042374L (no) 2004-08-09
WO2003039531A1 (en) 2003-05-15
DE60221691T2 (de) 2008-04-30
ES2287333T5 (es) 2019-04-29
EP1441713B1 (de) 2007-08-08
ES2256544T3 (es) 2006-07-16
NZ532592A (en) 2005-02-25
CZ16809U1 (cs) 2006-08-28
JP2011051995A (ja) 2011-03-17
IL161525A (en) 2012-12-31
RU2004117080A (ru) 2005-04-10
JP5536610B2 (ja) 2014-07-02
DK1443917T3 (da) 2006-07-17
DE60210315T2 (de) 2006-11-02
ES2287333T3 (es) 2007-12-16
ATE321544T1 (de) 2006-04-15
PT1441713E (pt) 2007-08-28
CN1298317C (zh) 2007-02-07
NL1021857C2 (nl) 2004-01-09
SI1441713T2 (sl) 2019-03-29
RU2335280C2 (ru) 2008-10-10
RU2004117081A (ru) 2005-03-20
WO2003039530A1 (en) 2003-05-15
NO340960B1 (no) 2017-07-31
CZ16813U1 (cs) 2006-08-28
JP2005511591A (ja) 2005-04-28
CN1589139A (zh) 2005-03-02
EP1595538A3 (de) 2006-02-22
CN1652760A (zh) 2005-08-10
NL1021857A1 (nl) 2003-05-08
IL161491A (en) 2009-07-20
RU2311903C2 (ru) 2007-12-10
DE60210315D1 (de) 2006-05-18
CA2465110A1 (en) 2003-05-15
CA2464689A1 (en) 2003-05-15
CN102327250A (zh) 2012-01-25
ZA200403281B (en) 2005-12-13
AT9978U1 (de) 2008-07-15
PT1443917E (pt) 2006-06-30
DE20220415U1 (de) 2003-10-09
EP1595538A2 (de) 2005-11-16
AU2002301845B2 (en) 2008-06-05
HU230830B1 (hu) 2018-07-30
DK1441713T4 (en) 2019-02-18
NO20042375L (no) 2004-08-09
IL161525A0 (en) 2004-09-27
NL1021822A1 (nl) 2003-05-08
HUP0401978A2 (hu) 2005-01-28
NL1021822C2 (nl) 2003-07-15
HUP0401978A3 (en) 2008-07-28
DE20221486U1 (de) 2006-02-02
EP1443917A1 (de) 2004-08-11
DE60221691T3 (de) 2019-04-04
SI1441713T1 (sl) 2007-10-31
IL161491A0 (en) 2004-09-27
DK200500297U3 (da) 2006-03-10
EP1441713A1 (de) 2004-08-04
HUP0402004A3 (en) 2008-08-28
SI1443917T1 (sl) 2006-06-30
JP2005512997A (ja) 2005-05-12
DE60221691D1 (de) 2007-09-20
EP1443917B1 (de) 2006-03-29
CZ16814U1 (cs) 2006-08-28

Similar Documents

Publication Publication Date Title
DE60221691D1 (de) Tamsulosin tabletten ohne nahrungsmitteleffekt
DE60204695D1 (de) Entsafter
DE60226103D1 (de) Heilnahrungsmittel
DE60201274D1 (de) Fritiergerät
FI20020265L (fi) Elintarvike
NO20042502L (no) Farmasoytisk formulering omfattende bicalutamid
UY3355Q (es) Caramelo
NO20033324L (no) Anti-stressmiddel
DE10107471B4 (de) Vitrine
FI20012292L (fi) Kasvisvalmiste
DE60237655D1 (de) Entwicklungsgerät
NO20012945D0 (no) Fat
FIU20010234U0 (fi) Pasta-tuote
UA5643S (uk) Хлібні горішки
ES1048195Y (es) Caramelo grotesco
SK3040U (sk) Potravinový doplnok
ITGE20010036A0 (it) Tostapane
FI5009U1 (fi) Tabletti
ITRG20010002U1 (it) Cream karrua
ATA14612001A (de) Portioniervorrichtung
UA5680S (uk) Кукурудзяні вироби
ES1049209Y (es) Barbacoa
UA5806S (uk) Кондитерський виріб
UA7000S (uk) Борошняні солодощі
ITTS20010019A1 (it) Apparecchio sgusciauova

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1441713

Country of ref document: EP